Efficacy of the current investigational drugs for the treatment of COVID-19: a scoping review
AbstractTo date, there is no final FDA-approved treatment for COVID-19. There are thousands of studies published on the available treatments for COVID-19 virus in the past year. Therefore, it is crucial to synthesize and summarize the evidence from published studies on the safety and efficacy of exp...
Main Authors: | Ahmed Wadaa-Allah, Marwa S. Emhamed, Mohammed A. Sadeq, Nesrine Ben Hadj Dahman, Irfan Ullah, Nesrine S. Farrag, Ahmed Negida |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2021.1875500 |
Similar Items
-
The role of angiotensin-converting enzyme 2 (ACE2) genetic variations in COVID-19 infection: a literature review
by: Manal S. Fawzy, et al.
Published: (2022-05-01) -
The COVID-19 pandemic: a systematic review of the current evidence
by: R. Ghomi, et al.
Published: (2020-11-01) -
SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants
by: John Charles Rotondo, et al.
Published: (2021-08-01) -
COVID 19: Dentistry related aspects
by: Hagar Alaa El-Naggar, et al.
Published: (2021-12-01) -
Current pandemic COVID-19 vaccine strategies and development: a comprehensive review
by: Hayat Ullah, et al.
Published: (2023-02-01)